Top of page Skip navigation

    Only a few options remain for this leading conference

We are delighted that the following organisations are supporting the 2016 conference.

Host Supporter


The Centre for Process Innovation is the UK’s national technology and innovation centre to serve and support the process manufacturing industries. We are chosen by key industry leaders and SMEs to develop, prove, prototype and scale up the next generation of products and processes.

We work across a range of technology platforms, each of which have the potential to generate a substantial impact on the future of manufacturing. We provide product and process development facilities and expertise in industrial biotechnology and biorefining, formulation and flexible manufacturing, printable electronics and biologics with the overall aim of creating less waste, cleaner, more efficient and more economic products and processes.

Poster Prize Supporter

Pall Life Sciences provides cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing biotech drugs, plasma-derived proteins, vaccines and classic pharmaceuticals. 

Pall’s leading edge filtration, single-use systems, separation, purification and analytical technologies, as well as technical services in validation, assays and process optimization applicable to laboratory and pilot-scale development, play an essential role in the industry’s ability to manufacture these products.  As an established provider of analytical and purification technologies, Pall supports faster development of new drugs and vaccines around the world.

Pre-conference Networking Evening Supporter

Merck a leading science and technology company in life science, offers products to safely and efficiently develop and manufacture therapeutics. Our products and services include single-use manufacturing, filtration, chromatography and purification, virus reduction, pharma and bio-pharma raw materials, drug delivery compounds, complex API manufacturing services, validation services and biopharmaceutical training. With the acquisition of Sigma-Aldrich, we now have the largest offering of products and services for formulations, actives and biotechnology processes.

Pre-dinner Drinks Supporter



Glythera is an early-stage Biotechnology company focused on the development of next-generation biologics, principally Antibody Drug Conjugates (ADCs) for cancer indications.


The Company’s ADC pipeline is based on an industry-leading, proprietary conjugation platform, ‘PermaLink’, which enables ADCs with higher therapeutic indices – a clear market need in fighting difficult-to-treat tumours. PermaLink is a cysteine-specific, non-maleimide approach that demonstrates significantly improved ADC conjugation stability and improved product homogeneity resulting in improved TI and patient safety profiles.


Through PermaLink, Glythera is able to combine novel, highly potent toxins that induce apoptosis with novel antibodies that target cancer-specific antigens, especially those that are highly overexpressed in solid tumors’.


The company is currently using its proprietary technology and access to a broad range of toxin payloads to develop a portfolio of class leading ADCs. Glythera is funded by IP Group and the North East Technology Fund and is based in Newcastle Upon Tyne, England .

onference Dinner Supporter


Hyper Recruitment Solutions (HRS) is a specialist and highly compliant recruitment consultancy dedicated to the Sciences. Run by biochemist, and Vice Chair of the REC Life Sciences Community, Ricky Martin, in partnership with Lord Alan Sugar, HRS provide bespoke recruitment solutions to companies and bioprocessing professionals on a permanent, contract and interim basis


One of HRS core focuses is the Pharmaceutical and Biotechnology with a particular expertise and interest in Bioprocessing across all upstream, downstream and associated services. In support of this HRS have a dedicated department exclusively made up of consultants with a prior background in either a biological or biochemical discipline. Our team are here to help you or your company, and should see us not as recruiters, but as scientists supporting science.

Event Supporters


Funded by Government, BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond by helping society to meet major challenges, including green energy, food security and healthier, longer lives.

Industrial Biotechnology and Bioenergy (IBBE) is one of BBSRC’s three strategic priority areas. BBSRC is actively working with partners to build a thriving IBBE sector and last year invested £50.4 million into research and innovation around energy, chemicals and biopharmaceuticals. Through BBSRC’s Networks in Industrial Biotechnology and Bioenergy (BBSRC NIBB) more than 600 companies are currently engaged in collaborative working with over 2,600 academics to find new approaches to tackle research challenges, translate research and deliver key benefits in IBBE.



The Engineering and Physical Sciences Research council (EPSRC) is the main UK government agency for funding research and training in engineering and the physical sciences. Working with UK universities, it invests around £800 million a year in world class research and training that has real impact on future economic development and improved quality of life.



Helping shape a new age of healthcare

There is no other life sciences company quite like GE Healthcare’s Life Sciences business.  Part of GE Healthcare, we are a $4 billion business of 11,500 people in over 100 countries, at work enabling a new era in medicine.  We have the agility and unmatched global capabilities that come with being part of a company that continually pushes the frontiers of science and technology.


For more than 60 years, GE Healthcare Life Sciences has supported the development and use of new therapies, helping accelerate the journey from biological understanding to clinical therapy. At GE Healthcare Life Sciences, we believe that the practice of science and medicine is at a turning point; we are on the cusp of understanding biological and genetic mysteries and uncovering treatments for complex diseases that would have been unthinkable just a few years ago. We are supporting the  development of more personalized and targeted therapies by advancing cell therapy. We are helping healthcare practitioners gain new understanding of the body and enabling earlier and more precise diagnosis of disease with our imaging technologies. And as the development of molecules and medicines becomes more complex, we are reimagining the processes and manufacturing operations that make large scale biopharmaceutical production possible.


Headquartered in the United Kingdom, we provide expertise and tools in biotechnology, life sciences and clinical diagnostics, supporting fields from basic cell, protein and drug discovery research, to large-scale biopharmaceutical manufacturing, and diagnostic imaging in diseases such as cancer, heart disease and neurological disorders.




MedImmune is the worldwide biologics research and development arm of AstraZeneca with its headquarters in Gaithersburg, Maryland (US).  Employing approximately 500 people, the MedImmune Cambridge site is a major R&D hub supporting the research and early development of the biologics portfolio, contributing to all of the MedImmune therapy areas.



As a division of Parker Hannifin Corporation, Parker domnick hunter brings motion and control to bioprocessing. Our high-purity solutions speed up development times, increase efficiency and safety, and enable reproducible product quality.

Incorporating SciLog®, our portfolio combines filtration, bioprocess containers, overmolded manifolds and sensors into scalable automated single-use solutions for normal flow filtration, tangential flow filtration, bioreactor maintenance, metering and dispensing.

Our solutions are supported by a dedicated international team of biopharmaceutical specialists so we are on hand wherever in the world our customers choose to manufacture their products.



Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, effectively and economically.


Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves.

Conference Dinner Entertainment Supporter



FUJIFILM Diosynth Biotechnologies is an industry leading Biologics Contract Development and Manufacturing Organisation with locations in Billingham, UK,  Research Triangle Park, NC and College Station, TX, USA.  FUJIFILM Diosynth Biotechnologies has extensive experience in the development and manufacture of recombinant proteins, vaccines, monoclonal antibodies, among other large molecules, expressed in a wide array of microbial, mammalian, and insect systems.  

The company offers a comprehensive list of services from cell line and strain development, including its proprietary pAVEway™ microbial and Apollo™ mammalian systems, to process development, analytical development, clinical and commercial manufacturing.  The UK and NC sites are FDA-approved for the production of commercial products.

Lunch Supporters


Allergan Biologics Ltd. (an affiliate of Allergan plc.) is a state of the art development and clinical manufacturing facility and is a Centre of Excellence for Biologics development. We are responsible for leading all aspects of bulk drug substance development for innovator and biosimilar products throughout their product lifecycle. We are a successful, dynamic business with a long and successful track record in producing a wide range of complex biopharmaceuticals. Currently employing 140 staff, we use state-of-the-art analytical and manufacturing technologies to ensure we deliver high quality and cost-effective new medicines with a competitive edge.

Allergan plc (NYSE: AGN) is a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The company is anchored by strong and sustainable brand franchises. The Allergan brand portfolio features six blockbuster franchises in key therapeutic categories, including Dermatology and Aesthetics; CNS; Eye Care; Women’s Health and Urology; GI and Cystic Fibrosis; and Cardiovascular and Infectious Disease. Allergan has global headquarters in Dublin, Ireland and U.S. Administrative Headquarters in Parsippany, New Jersey, USA.



Gemu are a worldwide manufacturer of process valves for the Bio-Pharmaceutical industries. Their HQ is in Germany and have over 1400 employees worldwide with over 20 factories or offices worldwide including the UK.

Products designed and manufactured include metal Diaphragm Valves which are aseptic in design and used in sterile processes such as WFI, Biotechnology fermentation and Pharmaceutical processes and filling. Plastic diaphragm valves are produced at their Swiss factory at Rotkreuz and a new separate 21,000 sq m Cleanroom facility at Emmen. High Purity Valves, fittings, flow sensors and controls for the world Semiconductor industries are produced there as well as plastic valve manifolds and the New Sumondo Single Use valves